SEC Form 4 · accession 0001683168-17-001465
International Stem Cell CORP · ISCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mahnaz Ebrahimi
Officer — Chief Financial Officer
Period of report
May 31, 2017
Accepted (ET)
Jun 1, 2017 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001355790
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.10 | May 31, 2017 | A | 40,000 | D | — | May 31, 2027 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F13/36th of the shares underlying such options shall vest on August 31, 2017, and the remaining share in equal monthly installments over a period of 33 months.